These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23761177)

  • 1. Chick embryo extract demethylates tumor suppressor genes in osteosarcoma cells.
    Mu X; Sultankulov B; Agarwal R; Mahjoub A; Schott T; Greco N; Huard J; Weiss K
    Clin Orthop Relat Res; 2014 Mar; 472(3):865-73. PubMed ID: 23761177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
    Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
    Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HDAC inhibitor Vorinostat diminishes the in vitro metastatic behavior of Osteosarcoma cells.
    Mu X; Brynien D; Weiss KR
    Biomed Res Int; 2015; 2015():290368. PubMed ID: 25785263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.
    Parashar S; Cheishvili D; Arakelian A; Hussain Z; Tanvir I; Khan HA; Szyf M; Rabbani SA
    Cancer Med; 2015 May; 4(5):732-44. PubMed ID: 25619880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic reprogramming underlies efficacy of DNA demethylation therapy in osteosarcomas.
    Asano N; Takeshima H; Yamashita S; Takamatsu H; Hattori N; Kubo T; Yoshida A; Kobayashi E; Nakayama R; Matsumoto M; Nakamura M; Ichikawa H; Kawai A; Kondo T; Ushijima T
    Sci Rep; 2019 Dec; 9(1):20360. PubMed ID: 31889115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific reversal of tumor-suppressor gene promoter hypermethylation with bovine oocyte extract.
    Wang Z; Gao H; Wang H; Ren X; Bao L; Sa R; Wang J; Bai H; Yu H
    Oncol Rep; 2013 Jul; 30(1):179-84. PubMed ID: 23670097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcoma.
    Leaner VD; Chick JF; Donninger H; Linniola I; Mendoza A; Khanna C; Birrer MJ
    Am J Pathol; 2009 Jan; 174(1):265-75. PubMed ID: 19074613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
    Khanna C; Khan J; Nguyen P; Prehn J; Caylor J; Yeung C; Trepel J; Meltzer P; Helman L
    Cancer Res; 2001 May; 61(9):3750-9. PubMed ID: 11325848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High SENP3 Expression Promotes Cell Migration, Invasion, and Proliferation by Modulating DNA Methylation of E-Cadherin in Osteosarcoma.
    Yang P; Liu Y; Qi YC; Lian ZH
    Technol Cancer Res Treat; 2020; 19():1533033820956988. PubMed ID: 33030103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.
    Lu J; Song G; Tang Q; Zou C; Han F; Zhao Z; Yong B; Yin J; Xu H; Xie X; Kang T; Lam Y; Yang H; Shen J; Wang J
    J Clin Invest; 2015 May; 125(5):1839-56. PubMed ID: 25822025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.
    Ren L; Mendoza A; Zhu J; Briggs JW; Halsey C; Hong ES; Burkett SS; Morrow J; Lizardo MM; Osborne T; Li SQ; Luu HH; Meltzer P; Khanna C
    Oncotarget; 2015 Oct; 6(30):29469-81. PubMed ID: 26320182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
    Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
    Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic reprogramming of human lung cancer cells with the extract of bovine parthenogenetic oocytes.
    Wang Z; Dao R; Bao L; Dong Y; Wang H; Han P; Yue Y; Yu H
    J Cell Mol Med; 2014 Sep; 18(9):1807-15. PubMed ID: 24889513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel interplay between HOTAIR and DNA methylation in osteosarcoma cells indicates a new therapeutic strategy.
    Li X; Lu H; Fan G; He M; Sun Y; Xu K; Shi F
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2189-2200. PubMed ID: 28730284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma.
    Itoh H; Kadomatsu T; Tanoue H; Yugami M; Miyata K; Endo M; Morinaga J; Kobayashi E; Miyamoto T; Kurahashi R; Terada K; Mizuta H; Oike Y
    Oncogene; 2018 May; 37(22):2903-2920. PubMed ID: 29515232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slit-Robo GTPase-Activating Protein 2 as a metastasis suppressor in osteosarcoma.
    Marko TA; Shamsan GA; Edwards EN; Hazelton PE; Rathe SK; Cornax I; Overn PR; Varshney J; Diessner BJ; Moriarity BS; O'Sullivan MG; Odde DJ; Largaespada DA
    Sci Rep; 2016 Dec; 6():39059. PubMed ID: 27966608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.
    Techavichit P; Gao Y; Kurenbekova L; Shuck R; Donehower LA; Yustein JT
    BMC Cancer; 2016 Nov; 16(1):869. PubMed ID: 27821163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose DNA demethylating therapy induces reprogramming of diverse cancer-related pathways at the single-cell level.
    Takeshima H; Yoda Y; Wakabayashi M; Hattori N; Yamashita S; Ushijima T
    Clin Epigenetics; 2020 Sep; 12(1):142. PubMed ID: 32958049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic TET-1 inhibition highlights different epigenetic behaviours of IL-1β and TNFα in tumour progression of OS cell lines.
    Bellavia D; Caruccio S; Caradonna F; Costa V; Urzì O; Raimondi L; De Luca A; Pagani S; Naselli F; Giavaresi G
    Clin Epigenetics; 2024 Oct; 16(1):136. PubMed ID: 39358792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.